Top Headlines
- Seeing less: Ocular Therapeutix initial public offering prices below desired range
- India's biotech budget seeks collaborations, clusters, innovation
- AGTC offer draws $30M; Genzyme deal adjusted, path clear for AMD bid
- Research organizations mobilize against data protection restrictions
- Enzyme family works via many mechanisms
Latest News
Analysis
No one in biotech – industry, academia, regulators, nonprofits or patients themselves – disputes that cancer drug development is at a critical juncture. A raft of young companies has joined early movers in the space and the pipeline is filled with promising drugs.
Our Habitat for All Things Science
Browning of white fat is key to onset of weight loss in cancer
LONDON – Cachexia, the wasting syndrome that is responsible for many deaths among people with cancer, occurs because – among other changes in the body – white adipose tissue (WAT) switches to become brown adipose tissue (BAT), a new study has found.
READ MORE »- Enzyme family works via many mechanisms »
- Genetic influence on puberty intertwined with growth control genes »
- Pre-eclampsia joins the roster of protein-folding disorders »
- New research findings, $650M cash pledge to bolster psychiatric space »
- Fatty acid transport protein defects linked to schizophrenia, autism »
- Study points to new promising Alzheimer's disease treatment »
- New method for organ preservation gives gift of time to surgeons »
- Virus-fighting T cells may aid in bone marrow transplants »
- Chasing down common pathology for neurodegenerative diseases »
Opinion
- A little irony here? FDA’s technical difficulties on social media webinar send folks a’Twitter’July 10, 2014 | 9:44 PM | Posted by: Marie Powers
- Old news, yet still making headlinesJune 13, 2014 | 4:11 PM | Posted by: Mari Serebrov
- Pigoons, politicians and the periodic table: BioWorld’s 8th annual biotech summer reading listJune 06, 2014 | 4:09 PM | Posted by: Marie Powers
- ASCO strides provide cold comfortJune 05, 2014 | 4:38 PM | Posted by: Randy Osborne
- Capturing cancer drugs' true value calls for clear thinkingMay 30, 2014 | 3:48 PM | Posted by: Michael Fitzhugh
Featured Report
Word on the Street
We have turned what was a scientifically forbidding and featureless landscape into a landscape that has toeholds and opportunities and glimmers of hope.
Steve Hyman Director of the Stanley Center for Psychiatric Research at the Broad Institute, on the identification of more than 100 genetic loci related to the risk of developing schizophrenia